Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy
Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy
Sponsor: Sanofi
A PHASE3 clinical study on Hypertension, this trial is completed. The trial is conducted by Sanofi and has accumulated 7 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Change History
7 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE3
-
Sep 2025 — Oct 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jul 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sanofi
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alexandria, Egypt, Aryanah, Tunisia, Barranquilla, Colombia, Beirut, Lebanon, Cairo, Egypt, Campinas, Brazil, Caracas, Venezuela, Casablanca, Morocco, Durango, Mexico, Guadalajara, Mexico and 10 more location s